Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic

A pilot program was initiated using whole genome sequencing (WGS) to diagnose suspected genetic disorders in the Genetics Clinic at Children's Hospital of Wisconsin. Twenty-two patients underwent WGS between 2010 and 2013. Initially, we obtained a 14% (3/22) diagnosis rate over 2 years; with subsequent reanalysis, this increased to 36% (8/22). Disease causing variants were identified in SKIV2L, CECR1, DGKE, PYCR2, RYR1, PDGFRB, EFTUD2, and BCS1L. In 75% (6/8) of diagnosed cases, the diagnosis affected treatment and/or medical surveillance. Additionally, one case demonstrated a homozygous A18V variant in VLDLR that appears to be associated with a previously undescribed phenotype.

[1]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[2]  J. Parboosingh,et al.  Mutations in VLDLR associated with ataxia with secondary vitamin E deficiency , 2013, Movement disorders : official journal of the Movement Disorder Society.

[3]  Chad A Shaw,et al.  Molecular Diagnostic Experience of Whole-Exome Sequencing in Adult Patients , 2015, Genetics in Medicine.

[4]  Cong Zhang,et al.  SoftPanel: a website for grouping diseases and related disorders for generation of customized panels , 2016, BMC Bioinformatics.

[5]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[6]  Eric W. Klee,et al.  Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing. , 2015, The Journal of molecular diagnostics : JMD.

[7]  L. Vissers,et al.  Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.

[8]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[9]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[10]  Eric Vilain,et al.  Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory , 2014, Genetics in Medicine.

[11]  A. Clark,et al.  Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants , 2012, Science.

[12]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[13]  Emily H Turner,et al.  Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.

[14]  Michael Brudno,et al.  Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine , 2016, npj Genomic Medicine.

[15]  L. Pusztai,et al.  Patient preferences regarding incidental genomic findings discovered during tumor profiling , 2016, Cancer.

[16]  D. Ledbetter,et al.  Toward clinical genomics in everyday medicine: perspectives and recommendations , 2016, Expert review of molecular diagnostics.

[17]  Clara Gaff,et al.  Patient safety in genomic medicine: an exploratory study , 2016, Genetics in Medicine.

[18]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[19]  A. Clarke,et al.  Genetic testing in asymptomatic minorsBackground considerations towards ESHG Recommendations , 2009, European Journal of Human Genetics.

[20]  B. Fernandez,et al.  Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care , 2015, Clinical genetics.

[21]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[22]  Martha Carlson,et al.  Whole Exome Sequencing in Pediatric Neurology Patients , 2016, Journal of Child Neurology.

[23]  Orion J. Buske,et al.  The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.

[24]  D. Ledbetter,et al.  Recommendations for the integration of genomics into clinical practice , 2016, Genetics in Medicine.

[25]  E. Worthey.  Analysis and Annotation of Whole‐Genome or Whole‐Exome Sequencing Derived Variants for Clinical Diagnosis , 2017, Current protocols in human genetics.

[26]  C. Eng,et al.  A large health system's approach to utilization of the genetic counselor CPT® 96040 code , 2011, Genetics in Medicine.

[27]  Euan A Ashley,et al.  Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.

[28]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[29]  Peter N. Robinson,et al.  Phenotype-driven strategies for exome prioritization of human Mendelian disease genes , 2015, Genome Medicine.

[30]  J. Mullikin,et al.  Early-onset stroke and vasculopathy associated with mutations in ADA2. , 2014, The New England journal of medicine.

[31]  B. Knoppers,et al.  Recommendations for returning genomic incidental findings? We need to talk! , 2013, Genetics in Medicine.

[32]  Mustafa Tekin,et al.  The promise of whole-exome sequencing in medical genetics , 2013, Journal of Human Genetics.

[33]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[34]  William A Gahl,et al.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine. , 2016, Molecular genetics and metabolism.

[35]  S. Satya‐Murti,et al.  Clinical exome sequencing in neurologic disease. , 2016, Neurology. Clinical practice.

[36]  D. Bick,et al.  Whole Exome and Whole Genome Sequencing – Community Plan Medical Policy , 2018 .

[37]  Jeremy M. Harris,et al.  Genomics in Clinical Practice: Lessons from the Front Lines , 2013, Science Translational Medicine.

[38]  Claudio J. Verzilli,et al.  An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People , 2012, Science.

[39]  C. Boerkoel,et al.  The NIH Undiagnosed Diseases Program: bonding scientists and clinicians , 2012, Disease Models & Mechanisms.

[40]  Diane Hauser,et al.  The IGNITE network: a model for genomic medicine implementation and research , 2015, BMC Medical Genomics.

[41]  Laurie D. Smith,et al.  A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases , 2015, Genome Medicine.

[42]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[43]  R. Sinke,et al.  Targeted Next‐Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics , 2013, Human mutation.

[44]  Damian Smedley,et al.  The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data , 2014, Nucleic Acids Res..

[45]  M. Weirauch,et al.  The 253‐kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3 , 2014, Pediatric Blood & Cancer.

[46]  Tao Wang,et al.  Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. , 2016, JAMA oncology.

[47]  Eric D Wieben,et al.  Implementing individualized medicine into the medical practice , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[48]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[49]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[50]  Lora J. H. Bean,et al.  Regulating whole exome sequencing as a diagnostic test , 2016, Human Genetics.

[51]  E. Palmaer,et al.  Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing , 2013, Genetics in Medicine.

[52]  P. Stenson,et al.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine , 2013, Human Genetics.

[53]  K. J. Johansen Taber,et al.  Challenges and Opportunities for Genomics Education: Insights from an Institute of Medicine Roundtable Activity. , 2016, The Journal of continuing education in the health professions.

[54]  In the Absence of Evidentiary Harm, Existing Societal Norms Regarding Parental Authority Should Prevail , 2014, The American journal of bioethics : AJOB.

[55]  Adam C. Siepel,et al.  PHAST and RPHAST: phylogenetic analysis with space/time models , 2011, Briefings Bioinform..

[56]  J. Timmermans,et al.  An FBN1 Deep Intronic Mutation in a Familial Case of Marfan Syndrome: An Explanation for Genetically Unsolved Cases? , 2014, Human mutation.

[57]  C. Thermes,et al.  Ten years of next-generation sequencing technology. , 2014, Trends in genetics : TIG.